Kettering Health
Kettering, Ohio 45429
8 studies enrolling now · 13 studies all time
What they study most
Advanced Solid Tumors, Brain Metastases, Brain Tumor, Brain Tumor - Metastatic, Brain Tumor, Adult Meningioma, Brain Tumor, Adult: Glioblastoma, Brain Tumor, Primary, Brain Tumor, Recurrent, COVID-19 Disease, Cardiac Events, Chronic Pain, Coronary; Ischemic
Studies at this site
- IS-001 Injection in Patients Undergoing Robotic-Assisted Colorectal Surgery — Recruiting now
- Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) — Recruiting now
- Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076) — Recruiting now
- DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes — Recruiting now
- REMASTer: REcurrent Brain Metastases After SRS Trial — Recruiting now
- TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer — Recruiting now
- Acute Pulmonary Embolism Treatment With the AlphaVac Multipurpose Mechanical Aspiration System and the AlphaReturn Blood Management System: Evaluation of Safety and Effectiveness — Recruiting now
- A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia. — Recruiting now
- Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism — Running, not enrolling
- Study of LAU-7b for the Treatment of Coronavirus Disease 2019 (COVID-19) Disease in Adults — Stopped early
- MACE CDS Software Master Enrollment Protocol — Withdrawn before enrolling
- REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1 — Stopped early
- Electrically Evoked Compound Action Potentials Human Observation Medtronic System Study (ECHO-MDT) — Completed